New Lung Cancer Treatment Breakthrough

Posted on

New Lung Cancer Treatment Breakthrough

New Lung Cancer Treatment Breakthrough Lung cancer is the leading cause of cancer deaths in the United States, resulting in more deaths each year than prostate cancer, breast cancer, and colorectal cancers combined. More than 221 200 new cases of lung cancer will be diagnosed in the United States this year, accounting for about 13 percent of all cancer diagnoses.

New Lung Cancer Treatment Breakthrough, new lung cancer treatment 2018, new lung cancer treatment in cuba, new lung cancer treatment 2017, new lung cancer treatment israel, new lung cancer treatment, new lung cancer treatment uk,

Historically, lung cancer has been difficult to treat. It is difficult to detect in its early stages and can take years to develop. Often, by the time a patient notices symptoms and is diagnosed, cancer has spread to other parts of the body that makes the disease more complicated to manage.

However, cancer experts are looking for potential ways to harness the power of the body’s immune system to help fight cancer. This approach is called immuno-oncology or immunotherapy.

Some of the latest findings in immuno-oncology will be presented at the next annual meeting of the American Society of Clinical Oncology (ASCO®) in Chicago at the end of the month. ASCO is the world’s first cancer research meeting and offers experts the opportunity to share the latest clinical research on this deadly disease.

New Lung Cancer Treatment Breakthrough

Dr. David R. Sedzro, a lung cancer physician, director of the Lung Cancer Research program at the Sarah Cannon Research Institute, joined me recently to share the latest ASCO news in the fight against cancer Lung. Joining him was patient advocate Steven Young, President & COO, Dario Lung cancer Medical Institute. Steven shared experiences from the patient’s point of view and explained the burden of this deadly disease.